James Crowley, Professor of Medicine Emeritus at Brown University, shared a post on LinkedIn:
“Dr. Carl June has not gotten the Nobel Prize yet but he is in the running because he is a leader in the development of CAR T cell immunotherapy, a cancer treatment that uses genetically modified immune cells to kill cancer cells.
June and his team at the University of Pennsylvania also developed the first FDA-approved gene therapy.
What is CAR T cell immunotherapy?
CAR T cell immunotherapy involves taking cells from a patient, reprogramming them, and then injecting them back into the patient. The reprogrammed cells, called CAR T cells, are able to kill target cells, such as cancer cells, with precision.
What are June’s accomplishments?
June and his team helped save the life of pediatric patient Emily Whitehead the first patient treated with CAR T cells! June and his team are now working on using CAR T cell therapy to treat other diseases, including pancreatic, ovarian, and brain cancer. June and his team are also even working on non-oncology conditions, such as heart failure and fibrosis.
Learn more about Dr. June and his lab at Penn Medicine on this video.”
More posts featuring James Crowley on OncoDaily.